Cryo-Save Group N.V. : Announcement determination of stock dividend ratio
(Thomson Reuters ONE) -
Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading
international stem cell storage company and the largest family stem cell bank in
Europe, announced today the determination of the stock dividend ratio related to
the dividend for the year ended 31 December 2011 as approved by the Annual
General Meeting of Shareholders on 16 May 2012.
The average price during the period 18 May 2012 up to and including 1 June 2012
was ? 3.47. The number of dividend rights giving entitlement to one Cryo-Save
Group N.V. share has on 1 June 2012 (after market) been set at 43 (or at the
choice of the banks or stockbroker where a shareholder holds its shares 4,300
dividend rights gives entitlement to 100 shares). Payment of stock dividend is
only made in whole shares; fractions of shares are settled in cash.
The Group announces that shareholders wish to receive a distribution in shares
for 29% of the total dividend.
The cash distribution will be payable and the shares will be delivered as per
14 June 2012.
In this context a total of approximately 63,000 new shares will be issued,
charged to the share premium reserve, representing a Euro equivalent of
approximately ?216,000. The cash dividend will amount to ?526,000 before
withholding 15% dividend withholding tax.
Paying Agent: Kempen & Co N.V.
Enquiries:
Cryo-Save Group + 31 (0) 575 548 998
Arnoud van Tulder, Chief Executive Officer
SPJ Financiële Communicatie (The Netherlands) +31 (0)20 647 8181
Kees Jongsma/Leon Melens
Daniel Stewart & Company plc (UK) + 44 (0) 20 7776 6550
Martin Lampshire
College Hill (UK) + 44 (0) 20 7457 2020
Rozi Morris/ Adrian Duffield
Free footage is available on www.videobankonline.com.
About Cryo-Save (www.cryo-save.com/group)
Cryo-Save, the leading international family stem cell bank, stores more than
200,000 samples from umbilical cord blood, cord tissue and adipose tissue. There
are already many diseases treatable by the use of stem cells, and the number of
treatments will only increase. Driven by its international business strategy,
Cryo-Save is now represented in over 40 countries on 3 continents, with ultra-
modern processing and storage facilities in Belgium, Germany, Dubai, India,
South Africa and France (validation in progress).
Please click here for full press release in PDF:
http://hugin.info/143308/R/1616900/515765.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Cryo-Save Group N.V. via Thomson Reuters ONE
[HUG#1616900]
Unternehmensinformation / Kurzprofil:
Datum: 01.06.2012 - 18:05 Uhr
Sprache: Deutsch
News-ID 152366
Anzahl Zeichen: 3412
contact information:
Town:
Zutphen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 265 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Cryo-Save Group N.V. : Announcement determination of stock dividend ratio"
steht unter der journalistisch-redaktionellen Verantwortung von
Cryo-Save Group N.V. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
